CANCELED: BME Seminar: Shelly Sakiyama-Elbert, Ph.D., BME Chair, The University of Texas at Austin
Friday,
March 13, 2020
11:00 AM - 12:00 PM
All are welcome, (attendance required for graduate students). Lunch is provided.
Shelly E. Sakiyama-Elbert, PhD, Professor and Department Chair of Biomedical Engineering, The University of Texas at Austin
Biomaterials for Drug Delivery and Cell Transplantation to Treat Nerve Injury
The development of biomaterials to serve as scaffolds for wound healing and tissue repair is crucial for successful tissue engineering. My research focuses on developing biomaterials that promote cell survival and/or differentiation after transplantation for the treatment of nerve injury. My lab has developed heparin-binding affinity-based drug delivery systems that sequester growth factors within scaffolds and release growth factors in response to cell in-growth during tissue regeneration. More recently we have combined these scaffolds with embryonic stem cell-derived neural progenitor cells and shown that the combination of fibrin scaffolds and growth factor delivery can enhance cell survival and differentiation of neural progenitor cells transplanted after spinal cord injury. Furthermore, we demonstrated this approach enhanced functional recovery after spinal cord injury, as assessed by gridwalk. In conclusion, fibrin scaffold containing our drug delivery system can serve as a platform for cell transplantation for many applications in regenerative medicine by tailoring the choice of growth factors and the cell type used.
Shelly E. Sakiyama-Elbert, PhD, Professor and Department Chair of Biomedical Engineering, The University of Texas at Austin
Biomaterials for Drug Delivery and Cell Transplantation to Treat Nerve Injury
The development of biomaterials to serve as scaffolds for wound healing and tissue repair is crucial for successful tissue engineering. My research focuses on developing biomaterials that promote cell survival and/or differentiation after transplantation for the treatment of nerve injury. My lab has developed heparin-binding affinity-based drug delivery systems that sequester growth factors within scaffolds and release growth factors in response to cell in-growth during tissue regeneration. More recently we have combined these scaffolds with embryonic stem cell-derived neural progenitor cells and shown that the combination of fibrin scaffolds and growth factor delivery can enhance cell survival and differentiation of neural progenitor cells transplanted after spinal cord injury. Furthermore, we demonstrated this approach enhanced functional recovery after spinal cord injury, as assessed by gridwalk. In conclusion, fibrin scaffold containing our drug delivery system can serve as a platform for cell transplantation for many applications in regenerative medicine by tailoring the choice of growth factors and the cell type used.
Status: CANCELED
LOCATION:
← BACK TO EVENTS
- Morningside
- Seminar
- Engineering
- Alumni
- Faculty
- Family-friendly
- Graduate Students
- Postdocs
- Prospective Students
- Public
- Staff
- Students
- Trainees
Date Navigation Widget
Getting to Columbia
Other Calendars
- Alumni Events
- Barnard College
- Columbia Business School
- Columbia College
- Committee on Global Thought
- Heyman Center
- Jewish Theological Seminary
- Miller Theatre
- School of Engineering & Applied Science
- School of Social Work
- Teachers College
Guests With Disabilities
- Columbia University makes every effort to accommodate individuals with disabilities. Please notify us if you need any assistance by contacting the event’s point person. Alternatively, the Office of Disability Services can be reached at 212.854.2388 and [email protected]. Thank you.